1-[(Bromoacetyl)oxy]pyrrolidine-2,5-dione, 97.0%, 1g

Dimethyl (2-oxo-3-(3-(trifluoromethyl)phenoxy)propyl)phosphonate, 95.0%, 5g

5-Aminobenzo[d]oxazol-2(3H)-one, 95.0%, 10g

2-(4-((4-Bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

(R)-3,3'-Bis(triphenylsilyl)-1,1'-bi-2-naphthol, 97%, 250mg

4-Aminostyrene (0.5% KOH pellets), 96.0%, 250mg

anti-c-myc-tag mouse monoclonal, 9E10, 100 µg

3,6-Difluoro-2-methoxybenzaldehyde, 97.0%, 25g

(S)-TERT-BUTYL 3-(3-METHOXY-3-OXOPROPANOYL)PIPERIDINE-1-CARBOXYLATE, 90.0%, 1g

1-((2,2,2-Trifluoroethyl)carbamoyl)cyclopropane-1-carboxylic acid, 500mg

3-Fluoro-6-(trifluoromethyl)picolinic acid, 98%, 1g

Ammonium heptamolybdate tetrahydrate, min. 99%, pa, 250 g, plastic packaging.

2-Amino-5-bromo-4-methoxybenzoic acid, 95.0%, 5g